Advertisement

The Scientist

» FDA

Most Recent

image: Neurosurgeons Banned from Research

Neurosurgeons Banned from Research

By | July 24, 2012

After treating terminally ill patients with an unauthorized experimental probiotic procedure, two California doctors can no longer participated in human research.

0 Comments

image: FDA Spies on its Own

FDA Spies on its Own

By | July 17, 2012

The federal agency's surveillance of staffers feared to be leaking confidential information about medical devices was wider than previously thought.

0 Comments

image: Sidestepping the Synthetic Drug Ban

Sidestepping the Synthetic Drug Ban

By | July 16, 2012

Chemists are already finding ways to circumvent a new federal law cracking down on marijuana and methamphetamine mimics.

0 Comments

image: Obama Signs FDA Bill

Obama Signs FDA Bill

By | July 11, 2012

The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.

0 Comments

image: Pharma Company Sues FDA

Pharma Company Sues FDA

By | July 10, 2012

The maker of a pregnancy medication takes action against the federal agency for not stopping pharmacies from making and selling cheaper versions of the drug.

2 Comments

image: A Placebo for Schizophrenia?

A Placebo for Schizophrenia?

By | June 26, 2012

The placebo effect in clinical trials of the mental disorder has increased over the past decade.

1 Comment

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: New FDA Review Process Debated

New FDA Review Process Debated

By | June 20, 2012

Industry experts discuss the agency’s plans to make the drug approval process more transparent.

0 Comments

image: @Pharma Branching Out

@Pharma Branching Out

By | June 11, 2012

More than half of pharmaceutical companies on Twitter use more than one handle.

0 Comments

image: FDA OKs Early Stage Trials

FDA OKs Early Stage Trials

By | June 5, 2012

The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Teknova
Teknova
Advertisement
Life Technologies